Abstract:Background and objective: Osteosarcoma is a common primary malignant tumor of bone, and doxorubicin is one of the most widely used therapeutic drugs. While the problem of doxorubicin resistance limits the long-term treatment benefits in osteosarcoma patients. The role of miRNAs and their target genes in osteosarcoma have become increasingly prominent. Currently, there is no report on miR-506-3p reversing doxorubicin resistance by targeting STAT3 in osteosarcoma. The purpose of this study was to investigate the molecular mechanism that overexpression of miR-506-3p reverses doxorubicin resistance in drug-resistant osteosarcoma cells. Methods: Doxorubicin-resistant osteosarcoma cells (U-2OS/Dox) were constructed by intermittent stepwise increasing stoichiometry. The target genes of miR-506-3p were predicted by bioinformatics approach and the targeting relationship between miR-506-3p and STAT3 was detected using dual luciferase reporter assay. U-2OS/Dox cells were treated with miR-506-3p overexpression and STAT3 silencing respectively. Then Western blot and RT-qPCR were used to detect the protein and mRNA expression levels of JAK2/STAT3 signaling pathway, drug-resistant and apoptotic associated molecules. The migration and invasion were assessed by cell scratch assay and transwell assay. The cell proliferative viability and apoptosis were investigated by CCK8 assay and flow cytometry assay. Results: U-2OS/Dox cells were successfully constructed with a 14.4-fold resistance. MiR-506-3p is directly bound to the 3′-UTR of STAT3 mRNA. Compared with U-2OS cells, the mRNA expression of miR-506-3p was reduced in U-2OS/Dox cells. Overexpression of miR-506-3p decreased the mRNA expression levels of JAK2, STAT3, MDR1/ABCB1, MRP1/ABCC1, Survivin and Bcl-2, and decreased the protein expression levels of p-JAK2, STAT3, MDR1/ABCB1, MRP1/ABCC1, Survivin and Bcl-2, and conversely increased Bax expression. It also inhibited the proliferation, migration and invasion of U-2OS/Dox cells and promoted cells apoptosis. The results of STAT3 silencing experiments in the above indicators were consistent with that of miR-506-3p overexpression. Conclusion: Overexpression of miR-506-3p could inhibit the JAK2/STAT3 pathway and the malignant biological behaviors, then further reverse doxorubicin resistance in drug-resistant osteosarcoma cells. The study reported a new molecular mechanism for reversing the resistance of osteosarcoma to doxorubicin chemotherapy and provided theoretical support for solving the clinical problems of doxorubicin resistance in osteosarcoma.

Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.

STAT3 Activation by IL-6 from Mesenchymal Stem Cells Promotes the Proliferation and Metastasis of Osteosarcoma.

Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2

Adipose-derived mesenchymal stem cells promote osteosarcoma proliferation and metastasis by activating the STAT3 pathway.

Osteosarcoma Cells Promote the Production of Pro-Tumor Cytokines in Mesenchymal Stem Cells by Inhibiting Their Osteogenic Differentiation Through the TGF-β/Smad2/3 Pathway

CXCR1/Akt Signaling Activation Induced by Mesenchymal Stem Cell-Derived IL-8 Promotes Osteosarcoma Cell Anoikis Resistance and Pulmonary Metastasis

miR-197-3p Promotes Osteosarcoma Stemness and Chemoresistance by Inhibiting SPOPL

Stem Cells in Tumour Microenvironment Aid in Prolonged Survival Rate of Cancer Cells and Developed Drug Resistance: Major Challenge in Osteosarcoma Treatment

Cisplatin-resistant Osteosarcoma Cells Possess Cancer Stem Cell Properties in a Mouse Model

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

Microrna-143 is Associated with the Survival of ALDH1+CD133+ Osteosarcoma Cells and the Chemoresistance of Osteosarcoma.

Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells

(E)-SIS3 Suppressed Osteosarcoma Progression Via Promoting Cell Apoptosis, Arresting Cell Cycle, and Regulating the Tumor Immune Microenvironment

Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines

Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.

Human Mesenchymal Stem Cells Promote Growth of Osteosarcoma: Involvement of Interleukin‐6 in the Interaction Between Human Mesenchymal Stem Cells and Saos‐2

Human Mesenchymal Stem Cells (hmscs) Target Osteosarcoma and Promote Its Growth and Pulmonary Metastasis.

Targeting the CtBP1-FOXM1 transcriptional complex with small molecules to overcome MDR1-mediated chemoresistance in osteosarcoma cancer stem cells

Exosomal miR-331-3p derived from chemoresistant osteosarcoma cells induces chemoresistance through autophagy

Attenuation of STAT3 Phosphorylation Promotes Apoptosis and Chemosensitivity in Human Osteosarcoma Induced by Raddeanin A.

Conditioned Medium of the Osteosarcoma Cell Line U2OS Induces Hbmscs to Exhibit Characteristics of Carcinoma-Associated Fibroblasts Via Activation of IL-6/STAT3 Signalling.